Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 02/11/20261 min de lecture
P95 Julius Clinical Becomes AKEURA, a Specialist CRO in Clinical Development and Real-World Evidence
Traduction automatique locale · Langue originale de la source
Résumé
The new name completes the integration of P95 and Julius Clinical, bringing clinical development and real-world evidence together in one specialist company built around the experts behind every study.
Langue originale de la source: GlobeNewswire — Mergers and AcquisitionsOuvrir le communiqué original →